Thomas Meteyer

Title: The Innovations of Thomas Meteyer

Introduction

Thomas Meteyer is a notable inventor based in Lansdale, Pennsylvania. He has made significant contributions to the field of gene expression modulation, holding a total of four patents. His work primarily focuses on the development of non-steroidal ligands for use in nuclear receptor-based inducible gene expression systems.

Latest Patents

One of Meteyer's latest patents involves diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex. This invention relates to a method that allows for the modulation of exogenous gene expression. The process involves an ecdysone receptor complex that includes a DNA binding domain, a ligand binding domain, a transactivation domain, and a ligand. This complex is contacted with a DNA construct that comprises the exogenous gene and a response element. The binding of the DNA binding domain to the response element, in the presence of the ligand, results in the activation or suppression of the gene.

Career Highlights

Meteyer is currently employed at Intrexon Corporation, where he continues to innovate in the field of biotechnology. His work has been instrumental in advancing the understanding of gene expression and its applications in various biological systems.

Collaborations

Throughout his career, Meteyer has collaborated with notable colleagues, including Robert Eugene Hormann and Colin M Tice. These collaborations have contributed to the development of his innovative patents and have enhanced the research efforts at Intrexon Corporation.

Conclusion

Thomas Meteyer is a distinguished inventor whose work in gene expression modulation has led to significant advancements in biotechnology. His contributions continue to influence the field and pave the way for future innovations.